Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Split-course Chemoradiotherapy for Recurrent NSCLC
NCT03006575Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2015
- Primary completion
- Jun 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, nedaplatin in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
docetaxelnedaplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03006575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006575.